CV6 Therapeutics
PrivateLast Round
Grant
Nov 2, 2022
Total Funding Raised
$3.45M
Company Overview
CV6 Therapeutics operates in Healthcare & Life Sciences and is based in Belfast. Its latest recorded funding round was a Grant round in November 2022.
CV6 Therapeutics is a biotechnology company that develops small-molecule combination therapies for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CV6 Therapeutics Comparables
Compare CV6 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breakpoint Therapeutics | 85% | |
| FoRx Therapeutics | 83% | |
| Hemispherian AS | 83% |
For institutional investors. Book with your work email.
CV6 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2022 | ||||
| VC Round | Nov 2, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CV6 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | VC Round |
| Invest Northern Ireland | Grant, VC Round |
| Clarendon Fund Managers | VC Round |
| Techstart Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 35% to 2.8K.
- Apr 16, 2026
Monthly visitors increased 32% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 23, 2026
CV6 Therapeutics Inc. is named Team of the Year at the 2026 Belfast Chamber Business Awards, held at ICC Belfast in the United Kingdom.
- recognized_asOct 23, 2026
At the 2026 AIB Business Eye Awards in Belfast on Oct 23rd '26, CV6 Therapeutics Inc. is named Innovative Company of the Year for its work developing first-in-class investigational medicines for cancer and inflammatory diseases.
- recognized_asOct 21, 2026
CV6 Therapeutics Inc. is named Team of the Year at the 2026 Belfast Chamber Business Awards, presented at ICC Belfast in Northern Ireland on Oct 21st '26.
- receives_awardOct 2, 2026
CV6 Therapeutics Inc. founder and CEO Dr. Robert D. Ladner was shortlisted for the CEO of the Year - Small Business & Start-Ups Award at the 2026 Business Post Leadership Awards in Northern Ireland on Oct 2nd '26, presented by the Business Post and powered by Grant Thornton.
- recognized_asSep 25, 2026
Belfast Chamber named CV6 Therapeutics Inc. a finalist in the Business Innovation and Team of the Year categories at its Belfast Chamber Business Awards, delivered in partnership with Bank of Ireland, on Sep 25th '26 in the United Kingdom.
For institutional investors. Book with your work email.
CV6 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CV6 Therapeutics's valuation, stock price, and market status.
Is CV6 Therapeutics a public or private company?
CV6 Therapeutics is a private company.
What is the current stock price of CV6 Therapeutics?
CV6 Therapeutics is a private company, so its shares have no public market price. Caplight tracks CV6 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CV6 Therapeutics worth (valuation)?
Valuation information for CV6 Therapeutics is not publicly available.
Can I buy CV6 Therapeutics stock?
CV6 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CV6 Therapeutics's last funding round?
CV6 Therapeutics's most recent funding round was Grant on November 2, 2022.
Who are the main investors in CV6 Therapeutics?
Key investors in CV6 Therapeutics include QUBIS, Invest Northern Ireland, Clarendon Fund Managers, Techstart Ventures.
Will CV6 Therapeutics IPO soon?
No public IPO plans have been announced for CV6 Therapeutics.
How can I track CV6 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in CV6 Therapeutics's shares on secondary markets.